Raphael Pharmaceutical Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
RAPHStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 14. Principal Accounting Fees and Services
We were billed the following fees for professional services rendered by our auditor Weinstein International CPA, for the years ended December 31, 2023 and 2022.
| 2023 | 2022 | |
|---|---|---|
| U.S. dollars in thousands | ||
| Audit fees (1) | 30,000 | 30,000 |
| Audit – related fees | - | - |
| Tax fees | - | - |
| All other fees | - | - |
| Total | 30,000 | 30,000 |
| (1) | Consists of fees for audit of the Company’s annual financial statements, audit of the financial statements of acquired subsidiaries, the review of interim financial statements included in the Company’s quarterly reports, consents, and the review of other documents filed with the Commission. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.